Optiver Holding’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Optiver Holding's APGE Position: Q3 2026 in Review
Optiver Holding sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 242 shares — an estimated $32.1K sold.
Optiver Holding first reported a position in APGE in Q3 2025 and held it in 4 quarters. The position peaked at $32.1K in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Optiver Holding reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Optiver Holding sold 242 Apogee Therapeutics shares in Q3 2026, an estimated $32.1K.
- Optiver Holding first reported a position in Apogee Therapeutics in Q3 2025 and held it in 4 quarters.
- Optiver Holding's Apogee Therapeutics position peaked at $32.1K in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.